Early screening and timely treatment are essential in stopping, or even reversing, liver damage from MASH (metabolic dysfunction–associated steatohepatitis).
MASH symptoms can be vague, nonspecific, or even absent. Some people who reported MASH symptoms prior to getting diagnosed experienced:
Abdominal pain
Nausea
Loss of appetite
Fatigue
Swelling in the abdomen
Because symptoms may not clearly indicate this disease, it's important to be aware of certain risk factors that may increase the likelihood of developing MASH.
Screening can expose MASH
Getting screened for MASH gives you the best opportunity for early detection, so you can take action. Why does this matter? When MASH is addressed early, liver damage may be stopped or even reversed.
Some health care professionals refer to MASH as a "silent" disease because many people do not experience symptoms. Even if they do, they may not connect those symptoms to MASH.
Advanced stages of MASH come with potential complications that may be anything but quiet, like liver cancer or liver failure due to cirrhosis. Fortunately, timely screening, detection, and management may help prevent future complications.
See what risk factors and other common conditions are associated with MASH.
The information provided is for educational purposes only.